Pieris Pharmaceuticals PIRS Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	153.56M	137.12M	114.31M	99.16M	95.49M	82.26M	87.54M	59.38M
Total Current Assets	127.63M	111.75M	90.9M	78.56M	73.42M	60.51M	66.47M	59.09M
Cash and Equivalents	117.76M	83.74M	54.26M	48.42M	38.64M	39.74M	44.94M	32.89M
Total Non-Current Assets	45.06M	44.22M	40.84M	36.5M	39.06M	38.46M	37.24M	287k
Total Liabilities	102.81M	83.67M	69.94M	63.4M	67.56M	66.8M	47.05M	28.87M
Total Current Liabilities	50.56M	39.48M	35.55M	33.52M	36.58M	42.88M	34.37M	28.87M
Total Non-Current Liabilities	52.24M	44.18M	34.4M	29.88M	30.98M	23.93M	12.68M	0
Common Equity	72k	74k	74k	74k	74k	74k	99k	99k
Retained Earnings	-257.14M	-262.25M	-272.58M	-282.32M	-290.42M	-303.6M	-299.63M	-310.38M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	35.06M	103.88M	141.34M	141.1M	105.01M	153.56M	95.49M	38.68M
Total Current Assets	32.67M	89.79M	135.38M	115.01M	75.72M	127.63M	73.42M	38.68M
Cash and Equivalents	29.36M	37.88M	74.87M	62.26M	70.44M	117.76M	38.64M	17.4M
Total Non-Current Assets	25.23M	11.52M	39.94M	51.35M	31.03M	50.76M	27.93M	26.76M
Total Liabilities	9.84M	92.35M	101.41M	89.75M	73.98M	102.81M	67.56M	11.92M
Total Current Liabilities	8.38M	45.78M	48.08M	27M	22.15M	50.56M	36.58M	11.92M
Total Non-Current Liabilities	1.46M	46.58M	53.33M	62.74M	51.84M	52.24M	30.98M	0
Total Equity	25.23M	11.52M	39.94M	51.35M	31.03M	50.76M	27.93M	26.76M
Common Equity	43k	45k	54k	55k	56k	72k	74k	98k
Retained Earnings	-102.67M	-120.31M	-147.07M	-174.18M	-211.41M	-257.14M	-290.42M	-314.96M